Categories: Business News

Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports

(Reuters) -Swiss drugmaker Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for over $70 per share, Bloomberg News reported on Sunday, citing a person familiar with…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by NewsX Syndication
Published: October 26, 2025 20:55:20 IST

(Reuters) -Swiss drugmaker Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for over $70 per share, Bloomberg News reported on Sunday, citing a person familiar with the matter. Reuters could not immediately confirm the report. (Reporting by Dheeraj Kumar in Bengaluru; Editing by Aidan Lewis)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by NewsX Syndication
Published: October 26, 2025 20:55:20 IST

Recent Posts

Technology-Driven Innovation Boosts India’s Economic Growth, Highlights Startup Expansion And Private Sector Participation: Jitendra Singh

Jitendra Singh said technology-driven innovation led by the DST has boosted India’s economic growth, highlighting…

May 4, 2026

Who Won In Bengal Election 2026? Check Result For Mamata Banerjee In One-Sided Fight With BJP

The Bharatiya Janata Party is heading towards a historic win in West Bengal. Trends show…

May 4, 2026

Who Will Be Puducherry CM? A Look At Top Contenders As AINRC Races Towards Majority

The Puducherry election results show the AINRC-led NDA nearing a majority, with N. Rangasamy emerging…

May 4, 2026